Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Markets At Low Ebb Despite UK Approval Of Pfizer/BioNTech Vaccine

Published 02/12/2020, 09:17

Despite the Pfizer/BioNTech vaccine receiving emergency use authorisation in the UK, the markets were at a low ebb on Wednesday, unable to build on Tuesday’s month-opening gains.

One would be tempted to think that the FTSE fared best after the bell – falling just 0.1% – because of the UK becoming the first Western nation to approve a vaccine.

However, it is likely instead because the pound is down 0.4% against the dollar and half a percent against the euro, following reports that there is tension within the EU over the number of concessions Michel Barnier and his negotiating team are potentially giving away to the UK.

The deadline for a deal is now less than a month, and it is currently hard to gauge just how close an agreement actually is. The pound can expect a few more mornings like this one before the year is over.

In the Eurozone the losses were more pronounced. The DAX slipped towards 13,300 as it dropped 0.7%, while the CAC teetered on the edge of 5,560 after a 0.4% drop.

Failing to close above 30,000 yesterday evening, instead finishing at 29,823, the Dow Jones is set to retreat this afternoon, the futures pencilling in a 130 point fall. It may take FDA approval of the Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) vaccines to get the Dow to spend more than a few hours at a time the right side of 30,000.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.